Compare EU & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EU | SOPH |
|---|---|---|
| Founded | 2009 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 361.2M | 374.1M |
| IPO Year | 2011 | 2021 |
| Metric | EU | SOPH |
|---|---|---|
| Price | $1.61 | $5.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $4.00 | ★ $7.50 |
| AVG Volume (30 Days) | ★ 2.8M | 89.3K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.76 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $43,155,000.00 | N/A |
| Revenue This Year | $212.11 | $23.09 |
| Revenue Next Year | $29.88 | $19.57 |
| P/E Ratio | $52.83 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.34 | $2.59 |
| 52 Week High | $4.19 | $5.70 |
| Indicator | EU | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 44.87 | 54.80 |
| Support Level | $1.34 | $4.54 |
| Resistance Level | $2.17 | $5.46 |
| Average True Range (ATR) | 0.10 | 0.34 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 65.00 | 61.25 |
enCore Energy Corp together with its subsidiary, is principally engaged in the acquisition, exploration, development and extraction of uranium resource properties in the United States. The Company is focused on the extraction of domestic uranium in the United States. The Company utilizes the In-Situ Recovery technology (ISR) to provide necessary fuel for the generation of clean, reliable, and carbon-free nuclear energy.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.